Collectively, our results indicate that Mtf1 expression suppressed the detrimental effects caused by mHTT in vitro and in two in vivo HD models, indicating that delivery of Mtf1 might represent a therapeutic strategy against HD. Here, MTF1 is linked to Huntington disease.